Lower Urinary Tract Symptoms
Pipeline by Development Stage
Competitive Landscape
9 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (13)
Total enrollment: 2,918 patients across 13 trials
Tetra-NIRS Clinical Study
Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH
Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH
Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)
Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms
Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms
MCS in the Treatment of Lower Urinary Tract Symptoms
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms
Management of LUTS by Community Pharmacists
PEEZY Midstream Urine Device Compared to Catheterized Urine Sample
Uro-NIRS Clinical Study
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.